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A novel multiprotein complex is required to generate the
prechylomicron transport vesicle from intestinal ER
Shahzad Siddiqi,* Umair Saleem,* Nada A. Abumrad,§ Nicholas O. Davidson,** Judith Storch,††
Shadab A. Siddiqi,§§ and Charles M. Mansbach II1,*,†

Abstract Dietary lipid absorption is dependent on chylomicron production whose rate-limiting step across the intestinal absorptive cell is the exit of chylomicrons from the
endoplasmic reticulum (ER) in its ER-to-Golgi transport
vesicle, the prechylomicron transport vesicle (PCTV). This
study addresses the composition of the budding complex
for PCTV. Immunoprecipitation (IP) studies from rat intestinal ER solubilized in Triton X-100 suggested that vesicleassociated membrane protein 7 (VAMP7), apolipoprotein
B48 (apoB48), liver fatty acid-binding protein (L-FABP),
CD36, and the COPII proteins were associated on incubation of the ER with cytosol and ATP. This association was
confirmed by chromatography of the solubilized ER over
Sephacryl S400-HR in which these constituents cochromatographed with an apparent kDa of 630. No multiprotein complex was detected when the ER was chromatographed in the
absence of PCTV budding activity (resting ER or PKC depletion of ER and cytosol). Treatment of the ER with antiapoB48 or anti-VAMP7 antibodies or using gene disrupted
L-FABP or CD36 mice all significantly inhibited PCTV generation. A smaller complex (no COPII proteins) was formed
when only rL-FABP was used to bud PCTV. The data support the conclusion that the PCTV budding complex in intestinal ER is composed of VAMP7, apoB48, CD36, and
L-FABP, plus the COPII proteins.—Siddiqi, S., U. Saleem,
N. Abumrad, N. Davidson, J. Storch, S. A. Siddiqi, and C. M.
Mansbach II. A novel multiprotein complex is required to
generate the prechylomicron transport vesicle from intestinal ER. J. Lipid Res. 2010. 51: 1918–1928.
Supplementary key words chylomicron • lipid absorption • vesicle
budding complex • CD36 • L-FABP
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Considerable information has been acquired on the
machinery necessary for the generation of the transport
vesicle that takes newly synthesized proteins from the endoplasmic reticulum (ER) to the Golgi, referred to as protein vesicles (1–4), and the order of their accretion to the
ER exit sites (ERES) (5). The initial observations described
uniform vesicles of ⵑ55–70 nm. Although it was proposed
that changing cage protein angles could enlarge these
protein vesicles to accommodate up to 100-nm-sized cargo
(2), this still would not be large enough to transport
chylomicrons whose diameter averages 250 nm. These
considerations led to the proposal that alternative budding machinery was needed for the prechylomicron transport vesicle (PCTV) whose diameter is 350–500 nm (6).
With respect to PCTV, besides the requirement for an
expanded vesicle, another unique feature is its need for
large-scale expansion and contraction of either the number or the size of the vesicles produced. During fasting in
the rat, for example, only 4 mol/h triacylglycerol (TAG)
is exported into the lymph (7). By contrast, during nearmaximal intraduodenal infusions of glyceryltrioleate, up
to 110 mol/h of TAG are exported into the lymph in
chylomicrons (8). Thus during the fasting state, either a
presumed minimal number of vesicles would be needed to
transport the small amount of TAG, which would be greatly
increased after a fatty meal, or, alternatively, using the
same number of vesicles as present in the fasting state, a
3-fold increase in the radius of the vesicles on fat feeding

Abbreviations: Apo, apolipoprotein; ER, endoplasmic reticulum;
ERES, ER exit site; I-FABP; intestinal fatty acid-binding protein; immunoprecipitation, IP; L-FABP, liver fatty acid-binding protein; PCTV,
prechylomicron transport vesicle; PKC, protein kinase C; TAG, triacylglycerol; VAMP7, vesicle-associated membrane protein 7; v-SNARE,
vesicle-associated soluble N-ethylmaleimide-sensitive factor attachment
protein receptor.
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METHODS
Materials
3

H Oleic acid (9.2 Ci/mM) was procured from Perkin Elmer
Life Sciences. Sephacryl S-400 High Resolution gel filtration

medium was purchased from GE Healthcare (Piscataway, NJ).
Immunoblot reagents were purchased from Bio-Rad. Enhanced
chemiluminescence (ECL) reagents were procured from GE
Healthcare. Protease inhibitor cocktail tablets were obtained
from Roche Applied Science. Other biochemicals used were of
analytical grade and purchased from Sigma (St. Louis, MO) or
local companies. Male Sprague Dawley rats, 150–200 g were purchased from Harlan (Indianapolis, IN).

Antibodies and proteins
Rabbit anti-rat apolipoproteinB48 (apoB48) antibodies were
made from amino acid sequence 2055-2067 and rabbit anti-Sar1
antibodies were raised commercially (Protein Tech Group, Chicago, IL) using recombinant Sar1 protein (6). Polyclonal antibodies against rat VAMP7 were raised in rabbits commercially
(Genemed Synthesis, San Francisco, CA) using a synthetic 19mer peptide corresponding to amino acids 105-123 of rat VAMP7.
The antibody was purified against its immunogenic peptide (20).
Titration of the anti-VAMP7 antibody against PCTV budding is
shown in supplementary Fig. I. Antibody against purified rat intestinal fatty acid-binding protein (I-FABP) and rat liver fatty
acid-binding protein (L-FABP) were raised in rabbits commercially (Affinity Bioreagents, Golden, CO) and used at 1: 30,000 or
1:20,000 dilution for immunoblotting, respectively. Recombinant
L-FABP (rL-FABP) was produced in Escherichia coli without tags
and was isolated and delipidated (21) (11). Affinity-purified rabbit polyclonal anti-Sec24C antibodies were a gift of J. P. Paccaud
(University of Geneva, Geneva, Switzerland). Goat anti-Sec 23,
rabbit anti-CD36, and rabbit polyclonal anti-PKC were procured
from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-mouse
monoclonal antibodies to rBet1and GOS28 were purchased from
Stressgen (Ann Arbor, MI). Goat anti-rabbit IgG conjugated with
agarose beads was purchased from Sigma. Goat anti-rabbit IgG
and goat anti-mouse IgG conjugated with horseradish peroxidase
(HRP) were procured from Sigma Chemical Co. (St. Louis,
Mo).

Gene-disrupted mice
L-FABP⫺/⫺C57BL/6J congenic mice (backcrossed more than
10 generations to C57BL/6J animals) were generated (22).
CD36-null mice were backcrossed to C57BL/6J background mice
(23, 24). Both gene-disrupted mice were compared with agematched C57BL/6J mice (Jackson Laboratory).

Preparation of ER, Golgi, cytosol, and labeling
of enterocytes
Enterocytes from the proximal half of the male Sprague Dawley rats (or mice) small intestine were isolated and radiolabeled
with 3H-TAG as described (25). In brief, enterocytes were isolated
from intestinal villi, collected, incubated with albumin bound
3
H-oleate for 30 min at 35°C and washed with 2% BSA in PBS to
remove the excess 3H-oleate. The labeled enterocytes were homogenized using a Parr bomb, and the ER was isolated using a
sucrose density step gradient, which was repeated to purify the
ER that contained calnexin and calreticulin but neither GOS28
nor rab11 (6, 20). By TLC,(8) 4% of the radiolabel was in the
phospholipid fraction. In PCTV, isolated in prior studies (26),
3% of the radiolabel by TLC was in the phospholipid fraction.
The cis Golgi was isolated from nonradiolabeled enterocytes, and
marker proteins determined its purity. The preparation of cytosol was essentially the same as previously described (6).

Isolation of the PCTV budding complex
ER (1 mg) was incubated at 4°C for 1 h with native cytosol (2 mg)
and an ATP-regenerating system (6). 4°C was chosen to prevent

PCTV budding complex requires nine proteins

1919

Downloaded from www.jlr.org at UNIV OF CENTRAL FLORIDA, on March 19, 2019

would accommodate transporting the increased TAG (9).
In either case, a large vesicle would be needed for chylomicron transport. The advantage of separate machinery for
PCTV transport, in particular, is that it would avoid potential competition for components that could become limiting under maximal PCTV budding conditions, in addition
to providing a large trafficking vesicle.
In all cells there is continuous protein traffic between the
ER and Golgi. The majority of these protein cargoes use the
COPII budding machinery, consisting of an inner layer of
Sar1 and Sec23/24 and an outer layer of Sec13/31 to produce protein vesicles. The minimal machinery necessary for
the generation of cargo carrying protein vesicles has been
established using COPII proteins and liposomes (10, 11).
Certain cargoes, such as the amyloid precursor protein, require cytosolic proteins in addition to COPII (11), signifying
an expanded budding complex requirement. In the case of
PCTV, although COPII proteins are required for fusion with
the Golgi, specifically Sec24C (12), they are not necessary for
budding a cargo-containing vesicle from the ER membrane
(6), suggesting a different budding mechanism. Indeed we
showed that the small Mr protein, liver fatty acid-binding protein (L-FABP) (14.1 kDa), can generate cargo-carrying PCTV,
although the vesicle produced is incomplete in that it cannot
fuse with the Golgi (13). It seemed highly unlikely that
L-FABP alone could select cargo for inclusion in PCTV, deform the ER membrane, and enable fission from the membrane to produce a cargo-carrying transport vesicle because
of its small size compared with the COPII proteins (total,
369 kDa) required for the initiation of the vesicle that
transports newly synthesized proteins from the ER to the
Golgi (14). In the protein transport system, differing members of the five-protein COPII complex are each assigned
specific functions in vesicle assembly (15–17), supporting
the thesis that L-FABP would be unlikely to perform these
multiple functions on its own. In sum, the data suggested
that ER and/or cytosolic proteins other than the COPII
proteins are involved in the complex series of steps required for the formation of PCTV.
This article describes the identification of several proteins
used for PCTV budding from intestinal ER. The experiments
were based on using three known components of PCTV budding; namely, the unique cargo protein, apolipoprotein B48
(apoB48), which is present in all chylomicrons (18); vesicleassociated membrane protein 7 (VAMP7); the vesicle-associated soluble N-ethylmaleimide-sensitive factor attachment
protein receptor (v-SNARE) for PCTV (19); and L-FABP,
which as we showed, is able to initiate PCTV budding (13).
The results indicate that apoB48, L-FABP, VAMP7, and the
FA transporter CD36 are essential components of the PCTV
vesicle complex and that formation of the complex requires
PKC.

Supplemental Material can be found at:
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In vitro PCTV formation
PCTV containing 3H -TAG were formed from 3H-TAG-loaded
intestinal ER (6). In brief, ER (500 µg protein) was incubated at
37°C for 30 min with cytosol (1 mg protein) and an ATP-regenerating system. The incubation mixture was resolved on a continuous sucrose gradient, and PCTV was isolated from the light
portions of the gradient. The PCTV was concentrated using a
Centricon-10 filter (Millipore Corp., Bedford, MA).

Effect of antibody treatment on PCTV budding
Intestinal 3H-TAG-loaded ER (500 µg protein) was treated
with 10 µl of specific antibodies as required or IgG for 60 min at
4°C. The ER was washed with PBS to remove excess antibody and
then used in a PCTV budding assay as described above. The
PCTV was collected from the top of a continuous sucrose gradient, and its 3H-TAG-dpm was determined. In the case of VAMP7,
antibody titration was performed with 2.5–10 µl anti-VAMP7 antibody incubated with ER (supplementary Fig. I). 10 µl was used in
the reported experiments.

Immunodepletion of PKC from cytosol
Removal of PKC from cytosol was performed by immunodepletion (26). Cytosol (1 mg) was incubated with 20 µl of rabbit
polyclonal anti-PKC antibodies at 4°C for 4 h. Anti-rabbit IgG
conjugated with agarose beads was added, and the mixture was
stirred slowly at 4°C overnight .The antibody-protein complexes
were removed by centrifugation. Successful depletion PKC from
cytosol was obtained by three rounds of immunodepletion and
confirmed by immunoblot.

Removal of PKC from the ER
To remove PKC from ER membranes, ER was incubated with
2 M urea for 15 min at 4°C (26). ER membranes were washed
twice with cold PBS. The removal of PKC confirmed by
immunoblotting.

SDS-PAGE and immunoblot
Proteins were separated by SDS-PAGE and then transblotted
to nitrocellulose membranes (Bio-Rad). After incubation with
specific primary antibodies and peroxidase-conjugated secondary antibodies, labeled proteins were detected using ECL (Amer-
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sham Biosciences) and Biomax film (Eastman Kodak, Rochester,
NY).

Immunoprecipitation of proteins from ER membranes
Intestinal ER (200 µg protein) was solubilized in 1% Triton
X-100 and then centrifuged in a bench-top microcentrifuge. The
supernatant was incubated with specific bead-bound primary
antibodies (10–20 µl) with gentle rocking for 4 hrs at 4°C. 40 µl
of protein A or protein G agarose beads (Sigma) were added depending on the primary antibody and incubated for another 4 h.
The beads were collected by centrifugation, washed eight times
with PBS, and resuspended in SDS-PAGE loading buffer for immunoblot analysis.

Coimmunoprecipitation of proteins from the
multiprotein complex or monomer species as eluted
from the Sephacryl S-400 HR column
Peak column fractions (3 fractions) from the multiprotein
fractions and peak monomer fractions of apoB48, VAMP7, and
L-FABP from chromatography on the Sephacryl S-400 HR column as previously described were collected, and the proteins precipitated using TCA. The TCA was removed by washing with cold
acetone. The proteins were solubilized with 0.25 M sucrose in
PBS. Specific bead-bound antibodies to apoB48, VAMP7, or
L-FABP were incubated with the solubilized proteins for 4 h at
4°C. The beads were washed in PBS eight times to remove unattached proteins. The bead-bound proteins were separated by
SDS-PAGE after boiling in Laemmli’s buffer. Immunoblots for
apoB48, VAMP7, and L-FABP were performed on the transblotted proteins as indicated.

Measurement of TAG radioactivity
TAG radioactivity was determined by liquid scintillation as described (25).

RESULTS
Isolation of the PCTV budding complex and
identification of its components
The ability to isolate the PCTV budding complex is critically dependent on its stability so that its protein components remain interactive during the column isolation
procedures. We have previously shown that ER and cytosol
depleted of PKC cannot bud PCTV (26). That the components would likely remain together was suggested by
our prior data showing that once exposed to ATP and cytosol, intestinal ER membranes were able to bud PCTV 30
min after stopping further phosphorylation by replacing
the cytosol with PKC-depleted cytosol (26). PKC is necessary for PCTV budding (26).
Our first approach to the isolation of the complex was
to narrow the focus of potential proteins composing the
complex by a series of immunoprecipitation (IP) experiments beginning with four proteins that were known to be
required for PCTV generation. ApoB48, the nonexchangeable apolipoprotein of chylomicrons present in PCTV (6),
is the quintessential apolipoprotein of chylomicrons (27).
VAMP7 is the v-SNARE for PCTV (19). L-FABP initiates
PCTV budding (13). Sec24C, while not required for budding, is required for PCTV docking and fusion with the
Golgi (12). Further, Sec24 has been shown to function in
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active PCTV budding and consequent escape of PCTV component proteins (6). The ER was washed twice with cold PBS and
solubilized with 1% Triton X-100 in PBS (pH 7.2). The ER membranes, pre- or post-incubation with cytosol and an ATP regenerating system as indicated in the figure legends, were loaded on a
Sephacryl S-400 HR column (45 cm × 1.5 cm) previously equilibrated with 1% Triton X-100 in PBS (pH 7.2) with a 0.5 ml/min
flow rate and eluted with 1% Triton X-100 in PBS (pH 7.2) at
4°C. 1 ml fractions were collected, and the proteins from each
fraction were precipitated with trichloroacetic acid (TCA) and
immunoblotted with specific antibodies as indicated. Band density was measured using a GelDoc XR (Bio-Rad, Hercules, CA).
When PCTV budding using rL-FABP was required, 80 µg of rLFABP was used instead of native cytosol (13). In other studies as
shown in the figure legends, PKC depletion of ER and cytosol
was accomplished as described below, and the depleted ER and
cytosol incubated at 37°C for 30 min. The column was characterized by determining the elution volume of Dextran blue (taken
as the void volume, 0 ml), thyroglobulin (10 ml), apoB48 from
rat mesenteric lymph chylomicrons (8) (21 ml), conalbumin (27
ml), ovalbumin (33 ml), L-FABP (38 ml), and glucose (40 ml).
3
H-oleate, chromatographed over the column in 1% Triton
X-100, eluted at 14 ml.

Supplemental Material can be found at:
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TABLE 1.

their specific, smaller monomer Mr. Further, by incubating the ER at 4°C, we hoped that in the absence of PCTV
budding, the budding complex proteins would be maximized in the ER rather than removed by active PCTV budding because these proteins are concentrated in PCTV
versus the ER (6). Supplementary Figs. III–VI show the immunoblots on which the subsequent data are based.
ApoB48, VAMP7, L-FABP, and CD36 are PCTV budding
complex components
When ER was solubilized without exposure to cytosol or
ATP, apoB48 eluted from the column in the fractions expected for its monomer species (Fig. 1A), indicating that
fully translated apoB48 exists in ER unlinked to other proteins in the basal state. Similarly, L-FABP (Fig. 2A) eluted
in a volume expected for its monomer species in resting
ER. VAMP7 in basal ER mostly eluted as a larger protein
than the expected 25 kDa (Fig. 3A). The likely explanation for this is that VAMP7 is present either as a homodimer or a hexamer on isolation from the ER and requires
reducing conditions associated with the performance of
2D gels to disassociate the VAMP7 aggregates (20). Like
L-FABP, CD36 (Fig. 4A) eluted in a volume expected for
its monomer species in resting ER. L-FABP and CD36’s
lack of association in a protein complex was also true for
the COPII proteins Sar1, Sec24C, and Sec31 (supplementary Figs. VII-A, VIII-A, and IX-A).
By contrast, when ER was incubated with native cytosol
and ATP (6), apoB48 eluted in earlier fractions (Fig. 1B)
suggestive of a protein complex of ⵑ630 kDa compared
with its monomer Mr of ⵑ250 kDa (27). In concert with
the apoB48 data, L-FABP (Fig. 2B), VAMP7 (Fig. 3B), and
CD36 (Fig. 4B) all eluted in nearly the same volume as
apoB48, suggesting the possibility that each was associated
in a multiprotein complex of 630 kDa. This was also true
for Sar1, Sec24C, and Sec31 (supplementary Figs. VII-B,
VIII-B, and IX-B).
Since L-FABP is able to generate PCTV from ER membranes as a recombinant protein (13), we predicted that it
would also be able to generate a budding complex. To test
this, we incubated intestinal ER with rL-FABP, solubilized the ER in 1% Triton X-100, chromatographed it on

Immunoprecipitation of proteins associated with PCTV budding using proteins required for
PCTV budding as bait
Interactive Proteins

Bead-Bound
Antibodies
VAMP-7
ApoB48
Sec24C
L-FABP
I-FABP
CD36

Sec23

Sec24C

L-FABP

I-FABP

VAMP-7

ApoB48

Sar1

N
Y
Y
N
N
ND

Y
Y
#
N
N
ND

Y
Y
N
#
N
Y

N
Y
N
N
#
ND

#
Y
Y
Y
N
Y

Y
#
Y
Y
Y
Y

Y
Y
Y
Y
N
ND

Immunoprecipitation studies of ER membrane proteins related to PCTV budding. Specific antibodies to the
proteins listed in the left column (bead-bound antibodies) were used as bait in immunoprecipitation studies (see
“Methods”). The precipitated proteins for each bait protein were identified by immunoblot using the specific
antibodies shown in each column (interactive proteins). Proteins associated with the bait protein are identified as
follows: Y = interactivity; N = no interaction; # = identical proteins; ND = not done. Abbreviations: Apo, apolipoprotein;
I-FABP, intestinal fatty acid-binding protein; L-FABP, liver fatty acid-binding protein; VAMP7, vesicle-associated
membrane protein 7.
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cargo selection (17, 28). The results of using bead-bound
antibodies to these four proteins in IP experiments are
shown in Table 1. Intestinal ER was incubated with cytosol
and ATP at 4°C and probed with antibodies to specific
proteins as shown. The data show that VAMP7 interacts
with Sec24C, L-FABP, apoB48, and Sar1. ApoB48 is shown
to interact with Sec23, Sec24C, L-FABP, I-FABP, VAMP7,
and Sar1. L-FABP was shown to interact with VAMP7,
apoB48, and Sar1. Sec24C is shown to interact with Sec23,
VAMP7, apoB48, and Sar1. In addition, we used antibodies to I-FABP, which gave 21% the budding activity of
L-FABP (13). It interacted with apoB48 but not Sar1 or
VAMP7, to which L-FABP reacted. Unexpectedly, using
antibodies to L-FABP, we coimmunoprecipitated an 88
kDa protein that on immunoblot was the fully glycosylated
form of CD36 (29), which has a variety of lipid-related
functions (23, 30, 31). CD36 was found to interact with
L-FABP, aopB48, and VAMP7. In sum, these data gave us
information on the potential composition of the PCTV
budding complex. In addition to the data suggesting the
interactivity of the various proteins, these IP studies support the thesis that the proteins composing the PCTV budding complex as isolated from the ER would remain
together during subsequent chromatographic procedures.
Supplementary Fig. II shows the immunoblots on which
the data in Table 1 are based.
Since the protein-protein interactions identified in
Table 1 were performed in the cold, we proposed that this
should be reflected in their continued interactivity when
intestinal ER was solubilized by Triton X-100 after incubation with intestinal cytosol and ATP at 4°C or when the ER
was incubated with L-FABP alone. We further proposed
that the proteins would remain as monomers in the absence of cytosol or in the absence of PKC where no PCTV
budding occurs (6, 26), and therefore, these conditions
could serve as controls. If our assumptions were correct,
each of the proteins proposed to compose the PCTV budding complex should elute from the Sephacryl S-400 HR
column at the same, small elution volume, indicating a
large complex under conditions appropriate for budding.
Under conditions where no budding would be expected,
the proteins should elute at larger volumes consistent with
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Sephacryl S400-HR, and then immunoblotted the eluate
for apoB48 (Fig. 1C). ApoB48 had a broad elution volume
whose peak suggested a complex of ⵑ500 Mr (Fig. 1C),
smaller than when native cytosol was used. A smaller budding complex is the expected result as no COPII protein is
present on PCTV in the absence of cytosol and ATP. These

proteins, Sar1, Sec24C, and Sec31, presumably originating
from that already bound to ER membranes (6), were present only as monomers under these conditions (supplementary Figs. VII-C, VIII-C, and IX-C). By contrast to the
COPII proteins, L-FABP (Fig. 2C), VAMP7 (Fig. 3C), and
CD36 (Fig. 4C) all eluted in a volume similar to that of

Fig. 2. ER-L-FABP distributes differently across a Sephacryl S-400 HR column under various conditions.
Native ER membranes (1 mg protein) were incubated with no cytosol (A), cytosol plus ATP (B), rL-FABP
(C), PKC-depleted cytosol, and urea-washed ER (D). The treated ER was chromatographed, immunoblotted for L-FABP, and band densities were determined as in Fig. 1. ER, endoplasmic reticulum; L-FABP, liver
fatty acid-binding protein; PKC, protein kinase C.
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Fig. 1. Distribution of ER-apoB48 across a Sephacryl
S-400 HR column under differing conditions. In
each case (A–D), ER membranes (1 mg protein) were
treated as indicated, collected by centrifugation,
washed with PBS, and solubilized in 1% Triton X-100.
The ER protein was chromatographed over a 1% Triton X-100 equilibrated Sephacryl S-400 HR column
(see “Methods”), and 1-ml fractions were collected.
Each fraction was tested for apoB48 by immunoblot.
The band densities were quantitated by the GelDoc
XR imaging system. The resulting arbitrary density
units are reported. (A) Native ER membranes. (B) ER
incubated with native cytosol and ATP. (C) ER membranes incubated with rL-FABP without cytosol. (D)
Urea-washed ER incubated with PKC immunodepleted cytosol and ATP (see “Methods”). In A–C, incubations were at 4°C; in D, the incubation was at
37°C (see “Methods”). Apo, apolipoprotein; ER, endoplasmic reticulum; L-FABP, liver fatty acid-binding
protein; PKC, protein kinase C.
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Fig. 3. ER-VAMP7’s distribution across a Sephacryl
S-400 HR column under various conditions. Incubation conditions and chromatography were as in Fig.
1. Solubilized ER membranes after treatment as indicated were chromatographed and fractions immunoblotted for VAMP7. (A) Native ER, (B) ER after
incubation with cytosol and ATP, (C) ER after incubation with rL-FABP, and (D) ER after incubation with
urea-washed ER and PKC-depleted cytosol. The
band densities were determined as in Fig. 1. ER, endoplasmic reticulum; L-FABP, liver fatty acid-binding
protein; PKC, protein kinase C; VAMP7, vesicle-associated membrane protein 7.

Formation of the PCTV budding complex requires PKC
In the last series of experiments, we wished to know if
a budding complex formed in the absence of PKC, a
condition where no PCTV budding occurs (26). For
these studies, PKC was immunodepleted from cytosol,
and the ER was washed with urea to remove PKC (26).
As shown in Fig. 1D, when the washed ER was incubated
with the depleted cytosol, no budding complex was detected, and apoB migrated near its monomer Mr as in

Fig. 1A. Urea-washed ER can generate both PCTV and
protein vesicles when incubated with cytosol and ATP
(6, 26), suggesting that urea treatment of the ER does
not impair the generation of PCTV. In sum, these data
suggest that in the absence of phosphorylation by
PKC, no budding complex occurs, providing a mechanism for the lack of PCTV budding activity under this
condition (26). In concert with the data for apoB48,
L-FABP (Fig. 2D), VAMP7 (Fig. 3D), and CD36 (Fig.
4D), all eluted in a volume of eluent consistent with
their respective monomer Mr. Similarly, Sar1, Sec24C,
and Sec31 all eluted in the volume expected for their
monomer species (supplementary Figs. VII-D, VIII-D,
and IX-D).

Fig. 4. The distribution of CD36 in a Sephacryl
S-400 HR column eluent of solubilized intestinal
ER treated as indicated in Fig. 1. Native ER membranes (A). ER membranes after incubation with native cytosol and ATP (B). ER membranes incubated
with L-FABP alone (C). Urea-washed ER membranes
incubated with PKC-depleted cytosol (D). The band
densities were determined as in Fig. 1. ER, endoplasmic reticulum; L-FABP, liver fatty acid-binding protein; PKC, protein kinase C.
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apoB48 (Fig. 1C), suggesting that these proteins associated in a multiprotein complex when L-FABP was the initiating protein, supporting the data obtained in Figs. 1B,
2B, and 3B.

Supplemental Material can be found at:
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Immunoprecipitation studies of the budding complex
We wished to confirm the interactivity of the proteins
comprising the budding complex by an alternative method
to coelution on column chromatography. For this purpose, we performed a series of immunoprecipitation studies using bead-bound antibodies to apoB48, VAMP7, and
L-FABP, and we identified the proteins that were coprecipitated. As shown in Fig. 5, when antibodies to apoB48
were used to precipitate proteins from the multiprotein
complex, VAMP7 and L-FABP were also precipitated, indicating their interactivity with apoB48 in the complex. By
contrast, when the anti-apoB48 antibodies were used to
immunoprecipitate apoB48 from fractions consistent with
the elution volume of its monomer species, only apoB48
was precipitated; neither VAMP7 nor L-FABP were precipitated. Similarly, antibodies to VAMP7 immunoprecipitated not only VAMP7 but also ApoB48 and L-FABP from

Fig. 5. Coimmunoprecipitation studies from column fractions
containing the multiprotein complex and from fractions containing monomer species of the proteins. Immunoblots that beadbound antibodies to apoB48, VAMP7, or L-FABP were used in
immunoprecipitation studies of Sephacryl S-400 HR column fractions, suggesting either a multiprotein complex (1, above the immunoblots) or, from fractions of the column eluent, the monomer
species of the indicated protein (2, above the immunoblots), as
judged from Figs 1–3. The immunoprecipitated proteins in each
case were separated by SDS-PAGE and immunoblotted for apoB48,
VAMP7, or L-FABP as indicated on the left side of the immunoblots. Apo, apolipoprotein; ER, endoplasmic reticulum; L-FABP,
liver fatty acid-binding protein; VAMP7, vesicle-associated membrane protein 7.
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the multiprotein complex; however, only VAMP7 was precipitated from the fractions where its monomer species
eluted. Finally, antibodies to L-FABP immunoprecipitated
not only L-FABP but also ApoB48 and VAMP7 from column fractions composing the protein complex; however,
only L-FABP was immunoprecipitated from fractions
where its monomer eluted. The protein-protein interactions from the column eluates (Fig. 5) are supported by
the interactivity of these proteins as isolated from ER membranes as shown in Table 1. An interpretation of these data
is that these three proteins not only coeluted from the column but also that they interacted as judged by their ability
to be coimmunoprecipitated.
Functionality of PCTV budding complex components
To support the composition of the PCTV budding complex, we sought to block the function of the components
of the complex either by immunologic or genetic means
to test their effect on PCTV budding activity. We reasoned
that if inhibiting the budding complex component resulted in reduced budding activity, the protein in question
could be considered important for complex formation
and consequent budding activity.
In the first series of experiments (Fig. 6), antibodies
to budding components VAMP7 and apoB48 were incubated with intestinal ER, the excess antibodies removed
by washing, and the ER used in a budding assay. The
results were compared with ER budding activity where
the ER was incubated with either IgG or antibodies to
ER components Bet1 and Sec22b, which are v-SNAREs
for ER-to-Golgi transport vesicles other than PCTV (32).
When the ER was incubated with antibodies to apoB48
or VAMP7, PCTV production was severely attenuated

Fig. 6. The effect of various antibody treatments on PCTV gen3
eration from rat intestinal ER membranes. H-TAG loaded intestinal ER was incubated with IgG. Excess IgG was removed by washing,
and the resulting ER incubated with intestinal cytosol and ATP.
Other ER membranes were incubated with anti-VAMP7, antiapoB48, anti-Bet1, or anti-rSec22b antibodies as indicated, the excess antibodies removed by washing, and the resulting ER incubated
with cytosol and ATP. The amount of PCTV budding activity was
determined (see “Methods”). The amount of PCTV budding activity using IgG was set to 100%. The percentage PCTV budding activity compared with ER incubated with IgG is reported on the
ordinate for each antibody used. The data are the mean ± SEM
(N = 4). The P values test the difference between the indicated
bars and ER treated with IgG. ER, endoplasmic reticulum; PCTV,
prechylomicron transport vesicle; TAG, triacylglycerol; VAMP7,
vesicle-associated membrane protein 7.
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The COPII proteins are part of the budding complex
We tested for other proposed components of the budding complex (Sar1, Sec24C, and Sec31) using the same
paradigm, expecting results as in the data above, except
that the COPII proteins were present only at their monomer elution volumes when L-FABP was used to initiate the
budding complex. These data are shown as supplementary
Figs. III–V. The other COPII proteins, Sec23 and Sec13,
were not tested.
In sum, the data support the thesis that in the presence
of cytosol and an ATP-generating system, proteins associated with PCTV budding are maintained in an interactive
complex. Further, L-FABP alone generates a slightly
smaller complex in the absence of the COPII proteins.
Under basal conditions, the ER contains the interactive
proteins in their monomer state. Similarly, under conditions where no PCTV budding is expected in the absence
of PKC, the components elute as monomers.
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ent in the cytosol of L-FABP KO mice; I-FABP has 22% of
the ability of L-FABP to bud PCTV from the ER (13).
We considered CD36 to play a potential role in PCTV
budding because CD36 gene-disrupted mice are less able
to export dietary lipid into the lymph than WT mice, and
they have an increase in mucosal TAG on dietary fat loading, suggesting a TAG transport defect (24, 34). Further,
CD36 was part of the PCTV budding complex (Fig. 4). We
tested CD36 KO mice for their ability to generate PCTV.
Consistent with the presence of CD36 in the PCTV budding complex (Fig. 4), ER and cytosol from CD36 KO mice
had only of 12% the PCTV budding activity of WT mice
(Fig. 8). We considered the possibility that in both CD36
and L-FABP KO mice, the ER was loaded with a reduced
amount of 3H-TAG compared with the WT mice as an explanation for the reduced PCTV production. However, we
found that the gene-disrupted mice had over 90% of the
amount of 3H-TAG loading as did the WT mice in both
cases (data not shown).

Fig. 7. Proteinase K digests a portion of apoB48 in intestinal ER
membranes. ER membranes, 150 µg protein, were incubated either with proteinase K (0.5 mg/ml) for 30 min at 4°C (Prot K),
without proteinase K (No Prot K), or with proteinase K and ER
membranes solubilized in 1% Triton X-100 (Triton + Prot K) as
indicated. All incubations with proteinase K were washed with 3 M
excess PMSF after the proteinase K incubations to stop further proteolysis. The ER was washed, and 30 µg of ER protein was separated
by SDS-PAGE, transblotted to a nitrocellulose membrane, and immunoblotted for apoB48. The arrows mark proteins migrating at
240 and 170 kDa. In other experiments performed in the same
manner, calreticulin was shown not to be attacked by proteinase K
in the absence of Triton X-100 (data not shown). Apo, apolipoprotein; ER, endoplasmic reticulum.

Fig. 8. CD36 and L-FABP gene-disrupted mice have impaired
generation of PCTV from intestinal ER. Mice whose CD36 or
L-FABP genes had been disrupted as indicated were used in a PCTV3
generation assay. H-TAG loaded ER from wild-type (WT) mice was
incubated with WT cytosol and the amount of PCTV budding activ3
ity determined by H-TAG-dpm quantitation (see “Methods”). This
activity was set to 100% (ordinate). CD36 knockout (KO) mice ER
and cytosol were used in a similar PCTV budding assay as shown.
L-FABP KO mice ER and cytosol were also tested for PCTV budding activity. The results are shown as a percentage of activity of the
WT mice. The data are the mean ± 1 SEM (n = 4). The P values test
the differences between the KO mice and the WT mice. ER, endoplasmic reticulum; L-FABP, liver fatty acid-binding protein; PCTV,
prechylomicron transport vesicle; TAG, triacylglycerol.

DISCUSSION
The PCTV budding complex from intestinal ER membranes that we describe is a composite of nine proteins.
Despite the numerous proteins involved, eight are associated with PCTV either as cargo (apoB48) (6), v-SNARE
(VAMP7) (19), Golgi-targeting proteins (COPII proteins)
(6), or a budding initiator protein (L-FABP) for PCTV
(13). The 9th protein, CD36, has been described as a fatty
acid translocase (23), a processor of dietary fat in intestinal ER (30), and a lipoprotein binder (31). The formation
of these nine proteins into a budding complex requires
cytosol and phosphorylation of a 9-kDa protein by PKC
(26). When L-FABP is used to generate the budding com-
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(Fig. 6). By contrast, when antibodies to Bet1, a protein
concentrated from ER in PCTV (6), were used, no decrease in budding activity was found compared with ER
incubated with IgG (Fig. 6). Similarly, antibodies to
Sec22b, a potential v-SNARE not present in PCTV (20),
did not affect budding activity (Fig. 6).
The results of apoB48 antibody inhibition suggest that a
portion of the apoB48 was on the cytosolic side of the ER
membrane. Consistent with this thesis, exposure of the ER
to proteinase K resulted in partial degradation of apoB48
in which a 70-kDa portion of the apoB48 was cleaved from
apoB48 (Fig. 7, No Prot K, 240 kDa), resulting in a 170kDa fragment (Fig. 7, Prot K). We have shown that the
ER-resident protein calreticulin is not attacked by proteinase K using the same conditions (data not shown). By contrast, the apoB48 signal was completely extinguished when
Triton X-100-disrupted ER was treated with proteinase
K (Fig. 7, Triton + Prot K). One interpretation of these
data is that a 70-kDa portion of apoB48 is exposed to
the cytosol and thus susceptible to proteinase K proteolysis. This data is in contrast with prior data in liver that
showed that apoB in ER was resistant to treatment with
proteinase K (33). Also in contrast to our data in ER showing partial degradation of apoB48, apoB48, when present
on chylomicrons in PCTV, is resistant to proteinase K treatment suggesting that it is protected by the vesicular membrane (6). Further, because our anti-apoB48 antibody is
polyclonal, it is not surprising that it can identify both the
full-length protein suggested by the data shown in Fig. 5
and the truncated one shown in Fig. 7.
L-FABP can initiate PCTV budding (13) and is part of
the budding complex identified (Figs. 2–4). To test the
importance of L-FABP in the generation of PCTV, we
tested the L-FABP gene-disrupted mouse model for its
ability to generate PCTV (Fig. 8). Only 21% of the activity
was found in the L-FABP knockout (KO) mouse compared
with the wild type (WT) controls. This amount of budding
activity is consistent with the known activity of I-FABP pres-
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GTP exchanger, Sec12 is not required with PCTV because
Sar1 does not need to be loaded with GTP (6). However,
in the case of PCTV, the transmembrane proteins VAMP7
and CD36 are needed as we show. A further distinction is
that Sec12 remains on the ER membrane after protein
vesicle budding, but with PCTV, VAMP7 and CD36 do not;
they are components of PCTV.
A fifth novel feature of PCTV is the mechanism of cargo
capture and required chaperones. As shown in Table 1,
five different proteins important for PCTV budding interact with apoB48, the major cargo protein. Although the
COPII proteins are important for Golgi targeting by PCTV
(12, 13), they are not required for cargo capture or budding from intestinal ER membranes (6). By contrast, both
the inner layer (Sar1, Sec23/24) and outer layers
(Sec13/31) of COPII are important for both protein cargo
and collagen transport from the ER (28, 47, 48). One possibility for the multiple differing proteins utilized for
apoB48 capture for PCTV is the size of apoB48 (250,000
kDa) and its hydrophobic nature. These parameters may
require these four proteins not only to capture cargo but
also to serve in part as chaperones. Typical of transport
vesicles, PCTV concentrate specific cargo proteins, such
as apoB48 and apoAIV (6), but exclude others; the ERresident proteins calnexin and calreticulin (6), Syn8,
the ER-to-Golgi vSNARE, Ykt6 (20), and apolipoprotein
apoAI (6).
The calculated kDa of the PCTV budding complex (766
kDa) is more than that predicted from the standardization
of the column by the elution volumes of proteins of known
kDa (ⵑ630 kDa). This could be due to binding of the complex to the column matrix. In the case of Sec23A/24C, this
led to a suggested kDa of 50 as judged by the elution volume from a size exclusion column, whereas the total kDa
of the proteins as suggested by their DNA was 210 (11).
The demonstration that CD36 is part of the PCTV budding complex provides a mechanistic explanation for the
defect in chylomicron production described in the CD36
null mouse (24, 34). CD36 has been shown to be important for uptake of fatty acids (23, 49) and cholesterol (49)
and may contribute to delivering the lipid to ER sites relevant for budding complex formation. However, its presence in the budding complex and the finding that PCTV
budding is almost completely eliminated in the absence of
CD36 suggests that it plays additional roles related to complex assembly or interaction with the ER membrane.
The most likely protein to initiate complex assembly is
L-FABP, which is present only in small amounts in native
ER but is abundantly present in cytosol (50). On incubation with cytosol and ATP, L-FABP (but not I-FABP) readily binds to ER membranes (13). More specifically, when
rL-FABP is incubated with ER, increased L-FABP binding
occurs (13). As we show, under both conditions large protein complexes form. It is of interest that our budding
complex assembled in the cold, confirming our pull-down
assays, suggesting that multiple protein-protein interactions occur in the absence of energy. Since PCTV budding
is not expected in the cold (6), the current data suggests
that ER membrane deformation and vesicle fission are
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plex, it is smaller, consistent with the absence of the cytosolic components of the complex, the COPII proteins.
The removal or functional blockade of any component of
the complex, except for the COPII proteins, either by antibody treatment or genetic disruption significantly attenuates the ability of the ER membrane to generate PCTV,
suggesting that each component of the complex needs to
function together to produce PCTV. The L-FABP and
CD36 KO mouse both result in nearly complete cessation
of PCTV budding activity. Specific antibodies to VAMP7
and apoB48 all significantly attenuate PCTV budding.
Because of the specialized nature of the cargo for PCTV
and the intermittency of its generation in relation to meals,
it is not surprising that its components are different from
other ER-to-Golgi transport vesicles whose cargo is constantly required either for intracellular utilization or for
export. First, because of size constraints, the Sec13/31
cage that encompasses typical protein transport vesicles
cannot contain chylomicrons, PCTV’s cargo (2). Chylomicrons are large, averaging 250 nm, significantly larger than
the typical ER-to-Golgi transport vesicle, ⵑ55–70 nm. The
proposed Sec13/31 cage can easily contain these smaller
vesicles, and the cage can even be enlarged to ⵑ100 nm
but not more, making them unable to accommodate chylomicrons (2).
Second, newly synthesized protein vesicles require the
COPII proteins for their generation, whereas PCTV do not
(6). Interestingly, increasing numbers of cargo proteins
are being recognized that either require cytosolic proteins
other than COPII to maximize vesicle generation (11) or
do not require COPII proteins at all for transport vesicle
formation (35–40). The specific cargoes transported by
COPII-independent mechanisms are diverse, encompassing both soluble and integral membrane proteins. The
lack of COPII proteins in these systems is associated with
vesicles that may either bypass the Golgi all together, indicating a loss of a Golgi targeting signal (36), or the vesicles
may be targeted to the Golgi despite a lack of the COPII
proteins (35, 37). In the case of PCTV, the COPII proteins
are required for PCTV-Golgi fusion (6, 12).
Another unique feature of intestinal ER is the presence
of VAMP7, a VAMP usually found in the post-Golgi fraction (41). With respect to PCTV, VAMP7 functions as the
v-SNARE (19) for fusion with the Golgi. It is not clear what
specific mechanism maintains VAMP7 in the ER in the intestine, although the N-terminal longin domain usually
determines its subcellular location (42, 43). A functional
role for VAMP7 in prechylomicron export in PCTV is suggested by an antibody blockade that significantly reduces
PCTV output by the ER as we show. Additionally, Caco2
cells that do not express VAMP7 in their ER (44) are poor
exporters of chylomicrons, although they synthesize TAG
(45) and the apolipoproteins associated with chylomicrons
(46).
This report adds a fourth novel feature of PCTV budding compared with the proteins that are transported
from the ER to the Golgi using the COPII protein system.
Whereas the only ER membrane protein required in the
COPII protein vesicle system is Sec12, which is the GDP-
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events that require incubation at 37°C. In this context,
L-FABP gene-disrupted KO mice have a significant but only
modest reduction in chylomicron output compared with
WT mice (51). This may be due in part to the ability of
I-FABP to generate PCTV, albeit at only a 22% rate of
L-FABP (13), or other unrecognized compensatory factors.

CONCLUSION
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